Key result
Direct hemoperfusion resulted in clinical improvement and recovery within several days in all 7 treated patients with neuroleptic malignant syndrome.
Why the study?
Does direct hemoperfusion improve recovery in patients with Neuroleptic Malignant Syndrome compared to standard medical therapy?
Observational (n=10)
Does direct hemoperfusion improve recovery in patients with Neuroleptic Malignant Syndrome compared to standard medical therapy?
Direct hemoperfusion may offer rapid clinical improvement and recovery in patients with neuroleptic malignant syndrome compared to standard pharmacotherapy.
Answers are grounded in this paper and cite their sources.
Direct hemoperfusion may hasten recovery in neuroleptic malignant syndrome; leaves open efficacy versus standard therapy in controlled trials.
Neuroleptic malignant syndrome (NMS) is an uncommon but serious and fatal idiosyncratic reaction to neuroteptics. It is difficult to correct this abnormalities successfully. There has been several reports on the treatment of NMS with dantrolene and/or bromocriptine. But these therapy are not effective in every cases.We have experienced ten cases of NMS. Six of them were presented with respiratory distress. Seven patients were treated with direct heraoperfusion and the remainder were managed by dantrolene, bromocriptine and other drugs. Patients treated with direct hemoperfusion two to four times could got a good improvement within several days and recovered. As to the patients treated by drugs. One of them who was not serious recovered with bromocriptine after twenty days. Two patients needed hemodialysis. NMS is occur not only by the use of neuroleptics but. also by the break of them. So, this syndrome is do not develop by the high concentration of neuroleptics merely. NMS differed from ordinary drug intoxication. The etiology of NMS has unknown. But two major theories are present. One is dopaminergic blockade theory the other is direct toxic effect on skeltal muscles. We speculate that direct hemoperfusion remove metabolites of neuroleptics or normalize the alteration in the central nervous system.
No takes yet. Share an insight, caveat, or question.
Masaji Nishimura (1991) conducted an observational in Neuroleptic Malignant Syndrome (n=10). Direct hemoperfusion vs. Medical therapy (dantrolene, bromocriptine, and other drugs) was evaluated on Clinical improvement and recovery. Direct hemoperfusion resulted in clinical improvement and recovery within several days in all 7 treated patients with neuroleptic malignant syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: